Gregory J. Baker
Gregory J. Baker
American Cancer Society (ACS) Postdoctoral Fellow, Harvard Medical School
在 hms.harvard.edu 的電子郵件地址已通過驗證 - 首頁
標題
引用次數
引用次數
年份
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
M Fallahi‐Sichani, V Becker, B Izar, GJ Baker, JR Lin, SA Boswell, P Shah, ...
Molecular systems biology 13 (1), 905, 2017
1162017
Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic …
GJ Baker, VN Yadav, S Motsch, C Koschmann, AA Calinescu, Y Mineharu, ...
Neoplasia 16 (7), 543-561, 2014
1092014
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors
KM Kroeger, AKMG Muhammad, GJ Baker, H Assi, MK Wibowo, W Xiong, ...
Discovery medicine 10 (53), 293, 2010
682010
Gene therapy for brain tumors: basic developments and clinical implementation
H Assi, M Candolfi, G Baker, Y Mineharu, PR Lowenstein, MG Castro
Neuroscience letters 527 (2), 71-77, 2012
542012
Natural Killer Cells Eradicate Galectin-1–Deficient Glioma in the Absence of Adaptive Immunity
GJ Baker, P Chockley, VN Yadav, R Doherty, M Ritt, S Sivaramakrishnan, ...
Cancer research 74 (18), 5079-5090, 2014
482014
Overview of current immunotherapeutic strategies for glioma
AA Calinescu, N Kamran, G Baker, Y Mineharu, PR Lowenstein, ...
Immunotherapy 7 (10), 1073-1104, 2015
422015
CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study
VN Yadav, D Zamler, GJ Baker, P Kadiyala, A Erdreich-Epstein, ...
Oncotarget 7 (50), 83701, 2016
382016
Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma
AKMG Muhammad, M Puntel, M Candolfi, A Salem, K Yagiz, C Farrokhi, ...
Clinical Pharmacology & Therapeutics 88 (2), 204-213, 2010
362010
Sequence effects of aminofluorene-modified DNA duplexes: thermodynamic and circular dichroism properties
SR Meneni, R D'Mello, G Norigian, G Baker, L Gao, MP Chiarelli, BP Cho
Nucleic acids research 34 (2), 755-763, 2006
342006
Blocking immunosuppressive checkpoints for glioma therapy: the more the Merrier!
MG Castro, GJ Baker, PR Lowenstein
Clinical cancer research 20 (20), 5147-5149, 2014
292014
Natural killer cells require monocytic Gr-1+/CD11b+ myeloid cells to eradicate orthotopically engrafted glioma cells
GJ Baker, P Chockley, D Zamler, MG Castro, PR Lowenstein
Oncoimmunology 5 (6), e1163461, 2016
162016
Isolation and flow cytometric analysis of glioma-infiltrating peripheral blood mononuclear cells
GJ Baker, MG Castro, PR Lowenstein
JoVE (Journal of Visualized Experiments), e53676, 2015
142015
Graft-versus-host disease propagation depends on increased intestinal epithelial tight junction permeability
SC Nalle, L Zuo, MLDM Ong, G Singh, AM Worthylake, W Choi, ...
The Journal of clinical investigation 129 (2), 902-914, 2019
102019
Lentiviral-Induced High-Grade Gliomas in Rats: The Effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H
J Lynes, M Wibowo, C Koschmann, GJ Baker, V Saxena, A Muhammad, ...
Neurotherapeutics 11 (3), 623-635, 2014
92014
Gene therapy for the treatment of neurological disorders: central nervous system neoplasms
N Kamran, M Candolfi, GJ Baker, MM Ayala, M Dzaman, PR Lowenstein, ...
Gene Therapy for Neurological Disorders, 467-482, 2016
72016
Pulses-winter
MM Miles, GJ Baker, W Hawthorne
Pests of Field Crops and Pastures. Identification and Control”(ed. PT Bailey …, 2007
72007
Sporadic ERK pulses drive non-genetic resistance in drug-adapted BRAFV600E melanoma cells
L Gerosa, C Chidley, F Froehlich, G Sanchez, SK Lim, J Muhlich, JY Chen, ...
bioRxiv, 762294, 2019
32019
Systemic Lymphoid Architecture Response Assessment (SYLARAS): An approach to multi-organ, discovery-based immunophenotyping implicates a role for CD45R/B220+ CD8T cells in …
GJ Baker, SK Palaniappan, JK Moore, SH Davis, S Santagata, PK Sorger
bioRxiv, 555854, 2019
22019
Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy
PR Lowenstein, GJ Baker, MG Castro
Oncoimmunology 3 (11), e965573, 2014
22014
MPTH-18STREAMS, VORTICES, AND NEUROSPHERES: IN VIVO NON-RANDOM LARGE SCALE SELF-ORGANIZATION OF GLIOBLASTOMA MULTIFORME AND THE ROLE OF NOVEL HISTOPATHOLOGICAL STRUCTURES
P Lowenstein, S Motsch, C Koschmann, F Nuñez-Aguilera, G Baker, ...
Neuro-oncology 17 (Suppl 5), v142, 2015
12015
系統目前無法執行作業,請稍後再試。
文章 1–20